Dengue is no longer just a tropical disease. As the climate warms, the dengue-carrying mosquito is expanding its reach to new regions. Despite this growing global threat, there is still no specific treatment for dengue. Together with our partners, we're working to change this!

In Latin America, 2025 was marked by important progress across our R&D portfolio & access initiatives. Our Latin America Activity Reports are now available. Explore the highlights & learn about our work across the region. 🔗 Portuguese: bit.ly/relatórioDNDi2025 🔗 Spanish: bit.ly/informeDNDi2025

🤝Acoziborole was made possible through a strong partnership with Sanofi, which contributed expertise in regulatory affairs, manufacturing and supply - complementing our role in bringing deep knowledge of #SleepingSickness and experience conducting clinical trials across Africa.

🎉 Our annual report is out! In 2025, we advanced work on 📋 33 projects, including 🔬 13 clinical trials in 6 disease areas, conducted across 📍 41 sites in 🌍 16 countries. To every partner and supporter standing with us: thank you 🙏 🔗 dndi.org/about/annual...

Have you registered for the upcoming webinar session on advancing research, diagnosis, & care for people with #mycetoma? Don't miss out on the conversation! 🗓️Thursday 16 July, 2026 🕒16:00-17:15 EAT / 1:00-2:15 GMT 🔗Register here➡️ us06web.zoom.us/webinar/regi... #MycetomaAt10 #BeatNTDs

Acoziborole is the result of two decades of scientific innovation & collaboration with many partners & donors that have joined us on this long journey to fight #SleepingSickness. Hear from @drluispizarro.bsky.social, our ED, on how medical innovation can bring hope to people affected.⤵️ #1Dose1Cure

We are delighted to announce that we are part of a drug discovery project on #mycetoma supported by @novo-nordisk.bsky.social and led by @erasmusmc.bsky.social in the Netherlands. Read more here: novonordiskfonden.dk/en/news/no-e...

We're pleased to announce that we have signed a licensing agreement with the @seruminstindia.bsky.social to support the development of what could become the world's first specific treatment for dengue. Read the press release: www.dndi.org/press-releas...

It's been 10 years since @who.int recognized #mycetoma as an #NTD. Join us for a webinar as we reflect on improving diagnosis, treatment & access. 📆 16 July, 16:00 EAT Register➡️ us06web.zoom.us/webinar/regi... #MycetomaAt10

🤝 How do you use crowdsourcing to design medicines that could work against coronaviruses? In this video, Fanny Escudié, our Senior Discovery Project Manager, shows how open science, AI, and global collaboration are accelerating discovery.

For decades, sleeping sickness was one of the most difficult challenges that MSF doctors had to confront in Central Africa. Today, 20 years after MSF & partners created DNDi, a revolutionary single-dose treatment for this disease stands ready to be distributed throughout the continent. @msf.ca

Today, we joined 7 PDPs to launch a call for sustained EU funding for EDCTP — supporting 20+ years of Europe–Africa clinical research, capacity strengthening, and innovation for global health security. Learn more: dndi.org/publications...

🥵 Rising temperatures are bringing #dengue to Europe. In this video, Sascha van Beek, German politician & nurse, explains why dengue is no longer a distant threat and why Germany & Europe need to prepare now. 👉 Investing in dengue research & innovation is a global priority. #ClimateChange

🎧 The third episode of our podcast is out! Many of Dr Al-Yafrosi’s patients are affected by cutaneous leishmaniasis, a neglected parasitic disease that can lead to acute social stigma, particularly for women and children. 👉 Available on Spotify & Apple Podcasts: open.spotify.com/episode/0pcW...

💊 Today, hope is growing for people like Mbo. The Democratic Republic of the Congo (DRC) has approved acoziborole, a single-dose oral treatment for sleeping sickness! @who.int #1Dose1Cure #StandWithScience

For years, mycetoma left Banchayehu from Ethiopia with a heavily swollen foot, unable to wear shoes or care for her 3 kids. After finding treatment at Boru Meda Hospital, she's reclaimed her life. Her journey reminds us why we advocate for early diagnosis & health equity. #MycetomaAt10 #BeatNTDs

⚽ Developing a treatment isn’t a solo run. It’s a team effort. As the world gets ready to kick off the #Football World Cup tomorrow, we’re spotlighting a different kind of squad 👉the one it takes to develop life-saving medicines for people with neglected diseases. #FIFAWorldCup

🦠 How do you design a medicine for a virus that doesn’t even exist yet? In this video, Fanny Escudié, our Senior Discovery Project Manager, breaks down how scientists are preparing for future pandemics with broad-spectrum antivirals.

We join forces with @gardp.bsky.social & @mmv.org to accelerate drug development for patients in greatest need! Emma Hannay, Chief Strategy Officer at MMV, explains why this collaboration is especially important in this changing global health ecosystem. 👉Press Release: dndi.org/press-releas...

We welcome the new Global Action Plan on #AMR, including commitments to strengthen R&D & ensure equitable access to treatments. We look forward to the Independent Panel for Evidence for Action against AMR and stress AMR must be central in global health reform discussions. dndi.org/statements/2...

Global health is high on the agenda at #WHA79, and voices like Dr @moniquewasunna.bsky.social's remind us what progress really looks like.

We welcome discussions on Global Health Architecture reform & stress biomedical innovation must be core. Market forces alone won’t deliver public‑health R&D. Reform must strengthen public‑interest models & ensure innovation is governed & financed for impact & equity. #WHA79 dndi.org/statements/2...

Coalitions matter – but how they’re built matters more. At the @isntd.org arbovirus event, @isabelaqribeiro.bsky.social highlights how the #DengueAlliance, led by endemic countries, is collaborating to close treatment gaps for dengue, with equity and access built in from the start. #WHA79

New health tools are vital for #NTD control & elimination. Partnerships have delivered breakthroughs like acoziborole, but gaps remain. We urge countries to finalize the NTD R&D blueprint, invest in inclusive research & drive innovation for climate‑sensitive diseases. #WHA79 dndi.org/statements/2...

We welcome continued efforts by Member States to advance the #PandemicAgreement & PABS annex. While negotiations continue, a PABS system – that delivers equitable innovation and access – is essential for preparedness. Read our full intervention here: dndi.org/statements/2... #WHA79 @who.int

We’ll be at the 79th World Health Assembly next week. Philip Kenol, our Senior Policy Advocacy Manager, shares our five key messages. 👉 Our call for this year’s #WHA79 is to build a global health system that delivers for those who have been neglected for far too long.

🎥 From Geneva, ahead of a particularly busy World Health Assembly our Executive Director @drluispizarro.bsky.social, shares the important topics we’ll be following closely next week. #WHA79 #GlobalHealth #NeglectedDiseases

New deadline 11 May The Board Treasurer is the chair of the DNDi Audit Committee, which assists the Board in its responsibility for overseeing the quality & integrity of the accounting, auditing, & reporting practices of DNDi and its compliance with the legal requirements. 👉 dndi.org/news/2026/dn...

📣 Joignez‑nous au webinaire du RF MTN @inserm.fr 📅 30 avril 2026 | ⏰ 13h–14h Nous partagerons notre engagement et notre expérience pour répondre aux besoins des populations négligées, autour de trois maladies clés. 🔗 Lien du webinaire: teams.microsoft.com/meet/3893168...

🎨 Did you know the colour of a tablet actually really matters? It’s not just about appearance 👉 colour plays an important role in how medicines are used and developed. #DrugDevelopment #GlobalHealth #ScienceExplained